MedPath

RESURGE THERAPEUTICS INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

RT-310 Dose Escalation BPH Study

Phase 1
Recruiting
Conditions
BPH (Benign Prostatic Hyperplasia)
Lower Urinary Tract Symptoms
First Posted Date
2023-11-18
Last Posted Date
2024-11-13
Lead Sponsor
Resurge Therapeutics Inc.
Target Recruit Count
20
Registration Number
NCT06136819
Locations
🇦🇺

Australian Clinical Trials, Wahroonga, New South Wales, Australia

🇦🇺

Goldfields Urology, Bendigo, Victoria, Australia

🇦🇺

Western Urology, Maribyrnong, Victoria, Australia

and more 1 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.